{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:13:48Z","timestamp":1740107628068,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract\u00a0\u00a0<\/jats:title><jats:p>Paraneoplastic neurological syndromes (PNS) can manifest with every type of malignancy. A well-known syndrome is myasthenia gravis (MG) in combination with thymomas. No association between primary brain tumors and neuromuscular disorders has been described. Here, we present a case of a 65-year-old patient who developed MG, following an uncomplicated, gross-total resection of a glioblastoma. To our knowledge, this is the first case describing the onset of MG during the early postoperative phase after glioblastoma resection. Current criteria of PNS are insufficient when the neurological syndrome is diagnosed at the time of a malignancy or shortly thereafter and should be revisited.<\/jats:p>","DOI":"10.1007\/s00701-021-05035-3","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T10:03:06Z","timestamp":1635501786000},"page":"423-427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Myasthenia gravis after glioblastoma resection: paraneoplastic syndrome or coincidence? A unique case report and review of the literature"],"prefix":"10.1007","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2537-428X","authenticated-orcid":false,"given":"R. J.","family":"Slegers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. A. M.","family":"Bouwens van der Vlis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ackermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hoeben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Compter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G. J.","family":"Hoeijmakers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Beckervordersandforth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P. G.","family":"Broen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. E. M. G.","family":"Schijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"5035_CR1","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1074\/mcp.M800596-MCP200","volume":"8","author":"I Babel","year":"2009","unstructured":"Babel I, Barderas R, D\u00edaz-Uriarte R, Mart\u00ednez-Torrecuadrada JL, S\u00e1nchez-Carbayo M, Casal JI (2009) Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics 8:2382\u20132395. https:\/\/doi.org\/10.1074\/mcp.M800596-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"5035_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jns.2014.07.060","volume":"346","author":"I Basta","year":"2014","unstructured":"Basta I, Pekmezovic T, Peric S, Nikolic A, Rakocevic-Stojanovic V, Stevic Z, Marjanovic I, Lavrnic D (2014) Extrathymic malignancies in a defined cohort of patients with myasthenia gravis. J Neurol Sci 346:80\u201384. https:\/\/doi.org\/10.1016\/j.jns.2014.07.060","journal-title":"J Neurol Sci"},{"key":"5035_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J (2010) A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol 10:46. https:\/\/doi.org\/10.1186\/1471-2377-10-46","journal-title":"BMC Neurol"},{"key":"5035_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/qjmed\/hcn152","volume":"102","author":"A Chaudhuri","year":"2009","unstructured":"Chaudhuri A, Behan PO (2009) Myasthenic crisis. Qjm 102:97\u2013107. https:\/\/doi.org\/10.1093\/qjmed\/hcn152","journal-title":"Qjm"},{"key":"5035_CR5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/jnnp.54.9.764","volume":"54","author":"GM Elrington","year":"1991","unstructured":"Elrington GM, Murray NM, Spiro SG, Newsom-Davis J (1991) Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry 54:764\u2013767. https:\/\/doi.org\/10.1136\/jnnp.54.9.764","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5035_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/archneurol.2009.341","volume":"67","author":"B Giometto","year":"2010","unstructured":"Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G (2010) Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 67:330\u2013335. https:\/\/doi.org\/10.1001\/archneurol.2009.341","journal-title":"Arch Neurol"},{"key":"5035_CR7","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler C, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135\u20131140. https:\/\/doi.org\/10.1136\/jnnp.2003.034447","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5035_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","volume":"257","author":"F Graus","year":"2010","unstructured":"Graus F, Saiz A, Dalmau J (2010) Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257:509\u2013517. https:\/\/doi.org\/10.1007\/s00415-009-5431-9","journal-title":"J Neurol"},{"key":"5035_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/cco.0000000000000222","volume":"27","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R, Rosenfeld MR, Dalmau J (2015) Update on neurological paraneoplastic syndromes. Curr Opin Oncol 27:489\u2013495. https:\/\/doi.org\/10.1097\/cco.0000000000000222","journal-title":"Curr Opin Oncol"},{"key":"5035_CR10","doi-asserted-by":"publisher","first-page":"e00465","DOI":"10.1002\/brb3.465","volume":"6","author":"M Koszewicz","year":"2016","unstructured":"Koszewicz M, Michalak S, Bilinska M, Budrewicz S, Zaborowski M, Slotwinski K, Podemski R, Ejma M (2016) Is peripheral paraneoplastic neurological syndrome possible in primary brain tumors? Brain Behav 6:e00465. https:\/\/doi.org\/10.1002\/brb3.465","journal-title":"Brain Behav"},{"key":"5035_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1212\/WNL.0b013e3182074a69","volume":"76","author":"TJ Lehky","year":"2011","unstructured":"Lehky TJ, Iwamoto FM, Kreisl TN, Floeter MK, Fine HA (2011) Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome. Neurology 76:236\u2013241. https:\/\/doi.org\/10.1212\/WNL.0b013e3182074a69","journal-title":"Neurology"},{"key":"5035_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2005.05.009","volume":"237","author":"N Levin","year":"2005","unstructured":"Levin N, Abramsky O, Lossos A, Karussis D, Siegal T, Argov Z, Ben Hur T (2005) Extrathymic malignancies in patients with myasthenia gravis. J Neurol Sci 237:39\u201343. https:\/\/doi.org\/10.1016\/j.jns.2005.05.009","journal-title":"J Neurol Sci"},{"key":"5035_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","volume":"12","author":"A Marx","year":"2013","unstructured":"Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Str\u00f6bel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12:875\u2013884. https:\/\/doi.org\/10.1016\/j.autrev.2013.03.007","journal-title":"Autoimmun Rev"},{"key":"5035_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11060-010-0471-7","volume":"104","author":"I Melguizo","year":"2011","unstructured":"Melguizo I, Gilbert M, Tummala S (2011) Guillain-Barr\u00e9 syndrome and glioblastoma. J Neurooncol 104:371\u2013373. https:\/\/doi.org\/10.1007\/s11060-010-0471-7","journal-title":"J Neurooncol"},{"key":"5035_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00415-020-09731-5","volume":"268","author":"F Petrelli","year":"2021","unstructured":"Petrelli F, De Stefani A, Ghidini A, Bruschieri L, Riboldi V, Dottorini L, Iaculli A, Zaniboni A, Trevisan F (2021) Steroids use and survival in patients with glioblastoma multiforme: a pooled analysis. J Neurol 268:440\u2013447. https:\/\/doi.org\/10.1007\/s00415-020-09731-5","journal-title":"J Neurol"},{"key":"5035_CR16","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/brain\/aww046","volume":"139","author":"KL Pitter","year":"2016","unstructured":"Pitter KL, Tamagno I, Alikhanyan K, Hosni-Ahmed A, Pattwell SS, Donnola S, Dai C, Ozawa T, Chang M, Chan TA, Beal K, Bishop AJ, Barker CA, Jones TS, Hentschel B, Gorlia T, Schlegel U, Stupp R, Weller M, Holland EC, Hambardzumyan D (2016) Corticosteroids compromise survival in glioblastoma. Brain 139:1458\u20131471. https:\/\/doi.org\/10.1093\/brain\/aww046","journal-title":"Brain"},{"key":"5035_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/mus.23502","volume":"46","author":"L Sharp","year":"2012","unstructured":"Sharp L, Vernino S (2012) Paraneoplastic neuromuscular disorders. Muscle Nerve 46:841\u2013850. https:\/\/doi.org\/10.1002\/mus.23502","journal-title":"Muscle Nerve"},{"key":"5035_CR18","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"5035_CR19","doi-asserted-by":"publisher","first-page":"13895","DOI":"10.1038\/srep13895","volume":"5","author":"P Syed","year":"2015","unstructured":"Syed P, Gupta S, Choudhary S, Pandala NG, Atak A, Richharia A, Manubhai KP, Zhu H, Epari S, Noronha SB, Moiyadi A, Srivastava S (2015) Autoantibody Profiling of Glioma Serum Samples to Identify Biomarkers Using Human Proteome Arrays. Sci Rep 5:13895. https:\/\/doi.org\/10.1038\/srep13895","journal-title":"Sci Rep"},{"key":"5035_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00415-018-8767-1","volume":"265","author":"A Vogrig","year":"2018","unstructured":"Vogrig A, Joubert B, Ducray F, Thomas L, Izquierdo C, Decaestecker K, Martinaud O, Gerardin E, Grand S, Honnorat J (2018) Glioblastoma as differential diagnosis of autoimmune encephalitis. J Neurol 265:669\u2013677. https:\/\/doi.org\/10.1007\/s00415-018-8767-1","journal-title":"J Neurol"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-021-05035-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-021-05035-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-021-05035-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T08:10:14Z","timestamp":1645085414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-021-05035-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["5035"],"URL":"https:\/\/doi.org\/10.1007\/s00701-021-05035-3","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"type":"print","value":"0001-6268"},{"type":"electronic","value":"0942-0940"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"18 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}